Michael Chez
Neurology with Special Qualifications in Child Neurology · Sacramento, CANPI 1003998618
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by UCB, Inc. at 31.8% of the total. Reporting peaked in 2022 at $76,829 and has fallen 62.1% since, to $29,109 in 2025. Among neurology with special qualifications in child neurology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 982 payments — averaging $381.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$119K
- Eisai Inc.$73K
- Neurelis, Inc.$42K
- Greenwich Biosciences, Inc.$23K
- SK Life Science, Inc.$18K
- Aquestive Therapeutics, Inc.$17K
- plus $82K from 22 others
Across 9 payments — averaging $8962.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eisai Inc.$44K
- GW Research Limited$37K
- UCB, Inc.$420
What the payments were for
- Consulting fees$143,23338%
- Speaking & faculty fees$184,94949%
- Travel & lodging$23,8696%
- Food & beverage$22,3056%
- Education$1010%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 435 | $119,052 |
| Eisai Inc. | 88 | $72,984 |
| Neurelis, Inc. | 52 | $42,270 |
| Greenwich Biosciences, Inc. | 66 | $22,795 |
| SK Life Science, Inc. | 47 | $18,097 |
| Aquestive Therapeutics, Inc. | 49 | $17,279 |
| Catalyst Pharmaceuticals, Inc. | 25 | $17,014 |
| Immedica Pharma US, Inc. | 39 | $16,868 |
| Zogenix Inc. | 18 | $12,692 |
| UCB SA | 4 | $9,090 |
| Jazz Pharmaceuticals Inc. | 50 | $8,140 |
| Mallinckrodt Hospital Products Inc. | 4 | $5,754 |
| Eisai CO., LTD. | 2 | $5,180 |
| Otter Pharmaceuticals, LLC | 1 | $1,674 |
| Biocodex, Inc. | 8 | $1,642 |
| Supernus Pharmaceuticals, Inc. | 14 | $1,588 |
| Sunovion Pharmaceuticals Inc. | 51 | $1,446 |
| Monteris Medical Corporation | 1 | $159 |
| Livanova USA, Inc. | 3 | $139 |
| Abbott | 1 | $124 |
| Mallinckrodt Enterprises LLC | 10 | $115 |
| Neuropace, Inc. | 2 | $82 |
| Medtronic | 1 | $80 |
| Tris Pharma Inc | 2 | $63 |
| Upsher-smith Laboratories LLC | 2 | $60 |
| Ceribell, Inc. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 5 | $24 |
| Acadia Pharmaceuticals Inc | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$374,457 in reported general payments places this provider in the 95th percentile of 216 neurology with special qualifications in child neurology providers in California.
See all neurology with special qualifications in child neurology providers in California →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EpidiolexCannabidiol (Cbd) | 17 | $76,147 |
| Levocarnitine | 14 | $657 |
| Divalproex Sodium | 18 | $485 |
| Risperidone | 21 | $300 |
| Clonazepam | 11 | $108 |
| Trazodone Hcl | 13 | $95 |
Paid to pharmacies, not to this prescriber.
Other neurology with special qualifications in child neurology in Sacramento
- Shailesh AsaikarSacramento$26K
- Temitayo ChidiSacramento$12K
- Allen BottOakland$372K
- Joseph SullivanSan Francisco$240K
- Ann SegerenStanford$172K
- Rajsekar RajaramanLos Angeles$134K
- Deborah HolderLos Angeles$130K
- Akash VirupakshaiahSan Francisco$94K
- Brittany PassiakSan Diego$90K
- Kevin ShapiroMadera$84K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.